Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy BMO Capital Markets

Vertex Pharmaceuticals Inc.
Start price
€327.35
02.08.23 / 50%
Target price
€355.55
02.08.24
Performance (%)
35.94%
End price
€445.00
03.08.24
Summary
This prediction ended on 03.08.24 with a price of €445.00. With a performance of 35.94% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Vertex Pharmaceuticals Inc. 1.794% 1.794% 30.146% 36.212%
iShares Core DAX® 0,44 % 5,90 % 8,05 % 65,58 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 % 90,18 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 % 84,99 %
iShares S&P 500 0,37 % 1,92 % 23,20 % 70,76 %

Comments by BMO_Capital_Markets for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 35.94%
Target price 355.546
Change
Ends at 02.08.24

Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten

BMO Capital Markets 
0
Report Share
03.08.24
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 35.94%
Target price 355.546
Change
Ends at 02.08.24

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $385.00 to $389.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat

BMO Capital Markets 
0
Report Share
02.08.23

Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€349.95
05.08.25
€458.50
05.08.26
20.02%
06.08.26

BMO Capital Markets 
05.08.25 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€379.90
20.12.24
€498.52
20.12.25
2.55%
21.12.25

BMO Capital Markets 
20.12.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€413.40
31.05.24
€459.80
31.05.25
-6.79%
01.06.25

BMO Capital Markets 
31.05.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€357.80
07.11.23
€388.11
07.11.24
30.65%
08.11.24

BMO Capital Markets 
07.11.23 50%